Webinar SOLACI – Medtronic | Impossible Cases! Review of Complex and Controversial TAVR Cases

We invite the entire Latin American community to analyze challenging TAVR cases together with a panel of Latin American experts. We will be looking at vascular access sites, aortic anatomy, potential coronary compromise, Valve-in-Valve, and more! 

Date: March 24, 2022, at 07.30 PM (Argentinian/ Brazil time; UTC-3).

The event will feature renowned experts from across the continent.

This event is open and free of charge. Take a look at the schedule below and sign up!


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Highlights of the SOLACI@EuroPCR 2025 Session

Relive the best moments of the joint session organized by SOLACI during the EuroPCR 2025 Congress on “Clinical and technical factors for decision-making in...

SOLACI Symposium at the EuroPCR 2025 Congress

The Latin American Society of Interventional Cardiology (SOLACI) makes a strong appearance once again at one of the most important congresses in the field...

See the best images from the Uruguay 2025 Sessions

Enjoy the best moments of the Uruguay 2025 Conference, held at the Radisson Hotel in Montevideo (Uruguay) on May 7, 8, and 9, 2025. <!--...

How to apply for the SOLACI Research 2025 Grant? Step-by-step explanation video

You can now rewatch the virtual event we held on April 9th, where we thoroughly reviewed the steps to apply for the SOLACI Research...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

PROSPECT II Substudy: Relationship Between Different Levels of hs-CRP and Vulnerable Plaque Characteristics in Patients with NSTEMI

Inflammation plays a key role in the onset and progression of atherosclerosis and has been linked to a higher risk of cardiovascular events, regardless...

Aspirin vs. Clopidogrel Monotherapy After 1 Month of ACS: Subgroup Analysis Based on Bleeding Risk and MI Type

Current guidelines still recommend dual antiplatelet therapy (DAPT) for 12 months following percutaneous coronary intervention (PCI) as the standard treatment in patients with acute...

iVAC2L: New Contribution to Ventricular Assist Devices in High Risk PCIs

The use of mechanical circulatory support (MCS) is on the rise, or increasingly necessary, seeing as high risk percutaneous coronary interventions (HR-PCIs) with severe...